Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jonathan O'B. Hourihane"'
Autor:
Caroline Nilsson, Montserrat Fernandez-Rivas, Antonella Muraro, Andrea Vereda, Alex Smith, Brian P. Vickery, Daniel C. Adelman, Audrey DunnGalvin, Kirsten Beyer, Vibha Sharma, Jonathan O'b Hourihane, Stacie M. Jones, Katharina Blumchen, George Du Toit, Robert Ryan
Publikováno v:
Allergy. 77:991-1003
Background: The benefit of daily administration of Peanut (Arachis hypogaea) Allergen Powder-dnfp (PTAH)-formerly AR101-has been established in clinical trials, but limited data past the first year of treatment are available. This longitudinal analys
Autor:
Gabriel Lins de Holanda Coelho, Audrey DunnGalvin, Matthew Greenhawt, Jonathan O'B Hourihane, David M. Fleischer, Gang Chen, Marcus Shaker, Dianne E. Campbell, Todd D. Green, Philippe Bégin
Publikováno v:
Allergy. 77(9)
The Food Allergy Quality of Life Questionnaire-Parent Form (FAQLQ-PF) is a commonly used patient-reported outcome measure in food allergy (FA) research. It was developed before FA treatment clinical trials were commonplace and is used as a secondary
Autor:
Jonathan O'b Hourihane, Áine Hennessy, Mairead Kiely, Louise C. Kenny, Lucio Malvisi, Deirdre M. Murray, Alan D. Irvine
Publikováno v:
Allergy. 73(11)
Background Prospective studies of antenatal and infant vitamin D exposure and atopic disease from extensively characterised, disease-specific, maternal-infant cohorts with gold standard analysis of vitamin D status and clinically validated atopic out
Publikováno v:
Allergy. 63:370-373
Background: Lupin has now been introduced into food production in the UK. There is a concern that, on account of cross-reactivity, peanut-allergic children are at high risk for lupin allergy. Aims: To investigate the prevalence of lupin sensitization
Publikováno v:
Allergy. 69(9)
Food allergy health-related quality of life (FAQOL) has been shown to improve after food challenge, but it is unknown whether this improvement is attributed to the procedure itself. Using the Food Allergy Quality of Life Questionnaire-Parent Form, we
Autor:
Barbara Ballmer-Weber, C. Ebner, Johannes Ring, Christina Schnopp, Denise-Anne Moneret-Vautrin, Claudio Ortolani, Jonathan O'b Hourihane, Thomas Werfel, U. Bengtsson, André C. Knulst, Morten Osterballe, Bodo Niggemann, Kristof Nekam, C. Blanco, Carsten Bindslev-Jensen
Publikováno v:
Allergy. 59(7)
At present, the double blind placebo controlled foodchallenge(DBPCFC)representstheonlywaytoestablishorruleoutanadversereactiontoafoodinolderchildrenand adults, whereas an open challenge controlled bytrained personnel is sufficient in infants and youn
Autor:
Jonathan O'b Hourihane
Publikováno v:
Allergy. 56
Down the years there have been many clinical reports of exquisite sensitivity to low doses of food allergens. There are many factors that may contribute to a variation of threshold in an individual exposed to an allergen during the course of his or h
Publikováno v:
Allergy. 60:536-537
Peanut allergy is a severe and life-threatening form of food allergy. Treatments are being developed but the mainstays of current management remain avoidance of peanut and appropriate use of rescue medication. We report the case of a boy with peanut
Autor:
Jonathan O'b Hourihane, Hans Bisgaard, Joachim Heinrich, Suzanne G.M.A. Pasmans, Ingo Marenholz, Peter Bager, Carol A. Wang, Niels J. Elbert, Tamara Schikowski, Lavinia Paternoster, Ana Esplugues, Young-Ae Lee, Donnchadh M. O'Sullivan, Chen Hu, Craig E. Pennell, Patrick G. Holt, Gunda Herberth, Natalia Ballardini, Mariona Bustamante, Adnan Custovic, Andrea von Berg, Mads Melbye, Erik Melén, Bo L. Chawes, Liesbeth Duijts, Maties Torrent, Jakob Stokholm, Marie Standl, Klaus Bønnelykke, Anna Bergström, Tarunveer S. Ahluwalia, John A. Curtin, Angela Simpson, Jacob P. Thyssen, Tamar Nijsten, Susanne Lau
Publikováno v:
Thyssen, J P, Ahluwalia, T S, Paternoster, L, Ballardini, N, Bergstrom, A, Melén, E, Chawes, B L K, Stokholm, J, Hourihane, JOB, O'Sullivan, D, Bager, P, Melbye, M, Bustamante, M, Torrent, M, Esplugues, A, Duijts, L, Hu, C, Elbert, N, Pasmans, SGMA, Nijsten, T, von Berg, A, Standl, M, Schikowski, T, Herberth, G, Heinrich, J, Lee, Y-A, Marenholz, I, Lau, S, Curtin, J A, Simpson, A, Custovic, A, Pennell, C E, Wang, C A, Holt, P G, Bisgaard, H & Bønnelykke, K 2020, ' Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis ', Allergy .
Allergy
Thyssen, J P, Ahluwalia, T S, Paternoster, L, Ballardini, N, Bergström, A, Melén, E, Chawes, B L, Stokholm, J, Hourihane, J O B, O'Sullivan, D M, Bager, P, Melbye, M, Bustamante, M, Torrent, M, Esplugues, A, Duijts, L, Hu, C, Elbert, N J, Pasmans, S G M A, Nijsten, T E C, von Berg, A, Standl, M, Schikowski, T, Herberth, G, Heinrich, J, Lee, Y A, Marenholz, I, Lau, S, Curtin, J A, Simpson, A, Custovic, A, Pennell, C E, Wang, C A, Holt, P G, Bisgaard, H & Bønnelykke, K 2020, ' Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis ', Allergy: European Journal of Allergy and Clinical Immunology, vol. 75, no. 6, pp. 1481-1485 . https://doi.org/10.1111/all.14162
Thyssen, J P, Ahluwalia, T S, Paternoster, L, Ballardini, N, Bergström, A, Melén, E, Chawes, B L, Stokholm, J, Hourihane, J O, O'sullivan, D M, Bager, P, Melbye, M, Bustamante, M, Torrent, M, Esplugues, A, Duijts, L, Hu, C, Elbert, N J, Pasmans, S G M A, Nijsten, T E C, Berg, A, Standl, M, Schikowski, T, Herberth, G, Heinrich, J, Lee, Y, Marenholz, I, Lau, S, Curtin, J A, Simpson, A, Custovic, A, Pennell, C E, Wang, C A, Holt, P G, Bisgaard, H & Bønnelykke, K 2020, ' Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis ', Allergy . https://doi.org/10.1111/all.14162
Allergy, 75(6), 1481-1485. Wiley-Blackwell Publishing Ltd
Allergy
Thyssen, J P, Ahluwalia, T S, Paternoster, L, Ballardini, N, Bergström, A, Melén, E, Chawes, B L, Stokholm, J, Hourihane, J O B, O'Sullivan, D M, Bager, P, Melbye, M, Bustamante, M, Torrent, M, Esplugues, A, Duijts, L, Hu, C, Elbert, N J, Pasmans, S G M A, Nijsten, T E C, von Berg, A, Standl, M, Schikowski, T, Herberth, G, Heinrich, J, Lee, Y A, Marenholz, I, Lau, S, Curtin, J A, Simpson, A, Custovic, A, Pennell, C E, Wang, C A, Holt, P G, Bisgaard, H & Bønnelykke, K 2020, ' Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis ', Allergy: European Journal of Allergy and Clinical Immunology, vol. 75, no. 6, pp. 1481-1485 . https://doi.org/10.1111/all.14162
Thyssen, J P, Ahluwalia, T S, Paternoster, L, Ballardini, N, Bergström, A, Melén, E, Chawes, B L, Stokholm, J, Hourihane, J O, O'sullivan, D M, Bager, P, Melbye, M, Bustamante, M, Torrent, M, Esplugues, A, Duijts, L, Hu, C, Elbert, N J, Pasmans, S G M A, Nijsten, T E C, Berg, A, Standl, M, Schikowski, T, Herberth, G, Heinrich, J, Lee, Y, Marenholz, I, Lau, S, Curtin, J A, Simpson, A, Custovic, A, Pennell, C E, Wang, C A, Holt, P G, Bisgaard, H & Bønnelykke, K 2020, ' Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis ', Allergy . https://doi.org/10.1111/all.14162
Allergy, 75(6), 1481-1485. Wiley-Blackwell Publishing Ltd
Atopic dermatitis (AD) is a prevalent inflammatory skin disease. Loss-of-function mutations in filaggrin gene (FLG) represent the strongest genetic risk factors for AD, being strongly associated with early disease onset and persistence into adulthood